Clinical Case Database / Category: Patient Management

Eosinophilic oesophagitis (EoE)

Publication details

Dr Rhys Hewett MBBS, MSc, MRCP, Dr Jamal Hayat BSc, MBBS, MRCP, Prof Jin-Yong Kang MD, PhD, FRCP, Dr Andrew Poullis BSc, MD, FRCP
Foundation Years Journal, volume 9, issue 2, p.34 (123Doc Education, London, February 2015)

Abstract

Eosinophilic oesophagitis (EoE) was first described in adult patients in the early 1980's and has since become an increasingly recognised cause of oesophageal dysfunction. It is characterised by symptoms, such as dysphagia and food bolus obstruction, in conjunction with characteristic endoscopic and histological appearances. Treatment usually consists of topical oesophageal steroids, but other therapies are also used. This case-based discussion will include clinical presentation, investigational findings, pathophysiology and management.

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

Authors

Dr Rhys Hewett MBBS, MSc, MRCP (Corresponding author)

Clinical Research Fellow, Department of Gastroenterology,
St George's Hospital, Blackshaw Road, Tooting, London, SW17 0QT
rhyshewett@doctors.net.uk

Dr Jamal Hayat BSc, MBBS, MRCP

Consultant Gastroenterologist, Department of Gastroenterology,
St George's Hospital, Blackshaw Road, Tooting, London, SW17 0QT
j.hayat@doctors.org.uk

Prof Jin-Yong Kang MD, PhD, FRCP

Consultant Gastroenterologist, Department of Gastroenterology,
St George's Hospital, Blackshaw Road, Tooting, London, SW17 0QT
jykang@sgul.ac.uk

Dr Andrew Poullis BSc, MD, FRCP

Consultant Gastroenterologist, Department of Gastroenterology,
St George's Hospital, Blackshaw Road, Tooting, London, SW17 0QT
apoullis@sgul.ac.uk

References

1. Desai TK, Stecevic V, Chang CH, et al. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc 2005, 61:795–801.
2. Trenkner SW, Maglinte DD, Lehman GA, et al. Esophageal food impaction: treatment with glucagon. Radiology 1983, 149(2):401-3.
3. Noel RJ, Putnam PE, Collins MH, et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004, 2(7):568-75.
4. Straumann A., Conus S., Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010, 139(5):1526–1537.
5. Gonsalves N, Yang GY, Doerfler B, et al. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 2012, 142(7):1451-9.
6. Cheng E, Zhang X, Huo X, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut 2013, 62(6):824-32.
7. Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy. Am J Gastroenterol 2013, 108(12):1854-1860.
8. Read AJ, Pandolfino JE. Biomechanics of esophageal function in eosinophilic esophagitis. J Neurogastroenterol Motil 2012, 18(4):357-64.
9. Rothenberg ME. Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009, 137:1238–1249.
10. Kagalwalla AF, Akhtar N, Woodruff SA, et al. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodelling and reverses with treatment. J Allergy Clin Immunol 2012, 129(5):1387-1396.
11. Kwiatek MA, Hirano I, Kahrilas PJ, et al. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology 2011, 140(1):82-90.
12. Korsapati H, Babaei A, Bhargava V, et al. Dysfunction of the longitudinal muscles of the oesophagus in eosinophilic oesophagitis. Gut 2009, 58(8):1056-62

Disclaimers

Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.